Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Cathy R. Schen, MD

Articles by Cathy R. Schen, MD

Making the Case for Community-Based Programs

ByCathy R. Schen, MD

October 6th 2016

Farming and Doctoring

ByCathy R. Schen, MD

July 31st 2013

Therapeutic farms that offer psychotherapy and psychopharmacology give patients an opportunity to learn about themselves.

Latest Updated Articles

Farming and Doctoring
July 31st 2013
Making the Case for Community-Based Programs
October 6th 2016

Trending on Psychiatric Times

Moving Away From Treatment-Resistant Depression and Toward Difficult-to-Treat Depression

The New, Impending Adult ADHD Guidelines

Reframing “Treatment-Resistant” as “Difficult-To-Treat”

Relief Is Not Free: A Case Study of Athlete Cannabis Use

Formulations Matter: The Approval of Olanzapine Extended-Release Injectable Suspension for Schizophrenia